Drugdiscovery >> Drugs >> News
4287
Views
Sanofi decides to withdraw the lixisenatide New Drug Application - drugdiscovery.com
Sanofi decides to withdraw the lixisenatide New Drug Application - drugdiscovery.com


Following discussions with the FDA regarding its proposed process for the review of interim data, Sanofi decided to wait with the NDA after completion of the ELIXA CV study.
Read More >>


Tags: Sanofi, new drug application,lixisenatide, ELIXA - September 13, 2013
Related Articles
6724
Views
New Drug Application for Delcath's drug rejected New Drug Application for Delcath's drug rejected
The FDA has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for Delcath Systems’ drug MelblezTM Kit, for the treatment of patients with unresectable ocular melanoma Read More >>

Tags: new drug application, NDA, Delcath, ocular melanoma, drug, Melblez, melphalan

2228
Views
New Drug Application for idelalisib New Drug Application for idelalisib
Gilead Sciences’ drug Idelalisib is an investigational, targeted, oral inhibitor of PI3K delta. If approved, it will be used for the treatment of indolent non-Hodgkin's lymphoma (iNHL). Read More >>

Tags: Gilead, idelalisib, new drug application, non-Hodgkin lymphoma

4465
Views
New Drug Application for AstraZeneca's hypertriglyceridaemia drug New Drug Application for AstraZeneca's hypertriglyceridaemia drug
The new drug application (NDA) for AstraZeneca's investigational hypertriglyceridaemia treatment, Epanova, has been accepted for standard review by the FDA. Read More >>

Tags: New Drug Application, AstraZeneca, hypertriglyceridaemia, drug, Epanova, FDA

11011
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

3958
Views
Nasacort now available over-the-counter in USA Nasacort now available over-the-counter in USA
FDA approved Sanofi's allergy drug to switch to OTC. Unlike other allergy medications that have previously been prescription-only but are not available over-the-counter, this is the first steroid medi Read More >>

Tags: Nasacort, Sanofi, allergy drug

2915
Views
New Drug Application for PENNSAID 2% accepted for FDA review New Drug Application for PENNSAID 2% accepted for FDA review
Mallinckrodt’s drug MNK-395 , or PENNSAID (diclofenac sodium topical solution) 2% is studied in the treatment of the osteoarthritis pain of the knee. Read More >>

Tags: Mallinckrodt, MNK-395, PENNSAID, diclofenac sodium, topical solution, pennsaid, pain, osteoarthritis, knee, FDA

4997
Views
 FDA accepts new drug application for  Merck's fertility treatment FDA accepts new drug application for Merck's fertility treatment
The new drug application (NDA) for Merck’s investigational fertility treatment, corifollitropin alfa, has been accepted for standard review by the FDA. If approved, the drug will be used in women Read More >>

Tags: Merck, assisted reproductive technology, fertility treatment, controlled ovarian stimulation, FDA, corifollitropin alfa

2538
Views
FDA accepts Endo’s long-acting testosterone injection application FDA accepts Endo’s long-acting testosterone injection application
The FDA has accepted for review new data for Endo’s long-acting testosterone injection- Aveed, intended for the treatment of hypogonadism. The ruling on the drug will be made by the end of February Read More >>

Tags: Endo, aveed, hypogonadism, testosterone injection, FDA approval

3028
Views
Clostridium difficile vaccine enters phase III clinical trial Clostridium difficile vaccine enters phase III clinical trial
Sanofi Pasteur is will recruit up to 15000 adults aged 50 or older and planning an upcoming hospitalisation or have had at least two hospital stays and have received systemic antibiotics in the past y Read More >>

Tags: Sanofi, vaccine, Clostridium difficile, C. diff, clinical trial

5127
Views
Nasacort  allergy nasal spray approved for OTC in US Nasacort allergy nasal spray approved for OTC in US
The FDA has approved Sanofi’s nasal spray as an over-the-counter (OTC) treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older. Read More >>

Tags: Sanofi, nasal spray, nasacort, OTC, allergy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013